Stevanato Group S.p.A.

General ticker "STVN" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $6.2B (TTM average)

Stevanato Group S.p.A. follows the US Stock Market performance with the rate: 44.3%.

Estimated limits based on current volatility of 2.4%: low 22.55$, high 23.66$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2025-06-05, amount 0.06$ (Y0.26%)
  • Total employees count: 4652 as of 2021
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [14.22$, 23.63$]
  • 2025-12-31 to 2026-12-31 estimated range: [14.81$, 24.43$]

Financial Metrics affecting the STVN estimates:

  • Positive: with PPE of 41.8 at the end of fiscal year the price was neutral
  • Positive: 7.86 < Operating profit margin, % of 14.60
  • Negative: Operating cash flow per share per price, % of 2.77 <= 6.82
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.52
  • Negative: Investing cash flow per share per price, % of -5.52 <= -4.48
  • Positive: Interest expense per share per price, % of 0.12 <= 0.79

Similar symbols

Short-term STVN quotes

Long-term STVN plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €983.68MM €1,085.35MM €1,104.04MM
Operating Expenses €791.25MM €884.63MM €942.89MM
Operating Income €192.43MM €200.72MM €161.14MM
Non-Operating Income €-4.79MM €-11.17MM €-0.85MM
Interest Expense €3.94MM €4.32MM €6.86MM
R&D Expense €34.39MM €35.67MM €31.67MM
Income(Loss) €187.64MM €189.55MM €160.29MM
Taxes €44.62MM €43.86MM €42.52MM
Profit(Loss)* €142.85MM €145.63MM €117.78MM
Stockholders Equity €996.13MM €1,132.53MM €1,404.34MM
Inventory €213.25MM €255.32MM €245.22MM
Assets €1,659.70MM €2,071.58MM €2,328.82MM
Operating Cash Flow €103.31MM €105.21MM €155.78MM
Capital expenditure €243.13MM €441.93MM €313.57MM
Investing Cash Flow €-242.95MM €-421.22MM €-310.21MM
Financing Cash Flow €-44.54MM €158.03MM €183.22MM
Earnings Per Share** €0.54 €0.55 €0.43

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.